ViroChem Pharma Overview

  • Founded
  • 2004
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $391M
Latest Deal Amount

ViroChem Pharma General Information


Developer and producer of the drugs and pharmaceutical products for viral disease. The company manufacture, develop and produce the medicine products for viral infection, Hepatitis C (HCV) and human immunodeficiency virus (HIV).

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 275 Armand-Frappier
  • Boulvard
  • Laval, Quebec H7V 4A7
  • Canada
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ViroChem Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 03-Mar-2009 $391M 00000 Completed Startup
1. Early Stage VC Completed Startup
To view ViroChem Pharma’s complete valuation and funding history, request access »

ViroChem Pharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BDC Healthcare Venture Fund Venture Capital Minority 000 0000 000000 0
To view ViroChem Pharma’s complete investors history, request access »